XB-ART-49839
J Gen Physiol
2014 Feb 01;1432:289-307. doi: 10.1085/jgp.201311097.
Show Gene links
Show Anatomy links
Aromatic-aromatic interactions between residues in KCa3.1 pore helix and S5 transmembrane segment control the channel gating process.
Garneau L
,
Klein H
,
Lavoie MF
,
Brochiero E
,
Parent L
,
Sauvé R
.
???displayArticle.abstract???
The Ca(2+)-activated potassium channel KCa3.1 is emerging as a therapeutic target for a large variety of health disorders. One distinguishing feature of KCa3.1 is that the channel open probability at saturating Ca(2+) concentrations (Pomax) is low, typically 0.1-0.2 for KCa3.1 wild type. This observation argues for the binding of Ca(2+) to the calmodulin (CaM)-KCa3.1 complex, promoting the formation of a preopen closed-state configuration leading to channel opening. We have previously shown that the KCa3.1 active gate is most likely located at the level of the selectivity filter. As Ca(2+)-dependent gating of KCa3.1 originates from the binding of Ca(2+) to CaM in the C terminus, the hypothesis of a gate located at the level of the selectivity filter requires that the conformational change initiated in the C terminus be transmitted to the S5 and S6 transmembrane helices, with a resulting effect on the channel pore helix directly connected to the selectivity filter. A study was thus undertaken to determine to what extent the interactions between the channel pore helix with the S5 and S6 transmembrane segments contribute to KCa3.1 gating. Molecular dynamics simulations first revealed that the largest contact area between the pore helix and the S5 plus S6 transmembrane helices involves residue F248 at the C-terminal end of the pore helix. Unitary current recordings next confirmed that modulating aromatic-aromatic interactions between F248 and W216 of the S5 transmembrane helical segment and/or perturbing the interactions between F248 and residues in S6 surrounding the glycine hinge G274 cause important changes in Pomax. This work thus provides the first evidence for a key contribution of the pore helix in setting Pomax by stabilizing the channel closed configuration through aromatic-aromatic interactions involving F248 of the pore helix. We propose that the interface pore helix/S5 constitutes a promising site for designing KCa3.1 potentiators.
???displayArticle.pubmedLink??? 24470490
???displayArticle.pmcLink??? PMC4001770
???displayArticle.link??? J Gen Physiol
???displayArticle.grants??? [+]
Species referenced: Xenopus laevis
Genes referenced: gnl3 kcna2 tbx2
???attribute.lit??? ???displayArticles.show???
References [+] :
Banderali,
New insights on the voltage dependence of the KCa3.1 channel block by internal TBA.
2004, Pubmed
Banderali, New insights on the voltage dependence of the KCa3.1 channel block by internal TBA. 2004, Pubmed
Bradding, The K+ channels K(Ca)3.1 and K(v)1.3 as novel targets for asthma therapy. 2009, Pubmed
Bruening-Wright, Evidence for a deep pore activation gate in small conductance Ca2+-activated K+ channels. 2007, Pubmed
Choveau, KCNQ1 channels voltage dependence through a voltage-dependent binding of the S4-S5 linker to the pore domain. 2011, Pubmed
Clarke, Domain reorientation and rotation of an intracellular assembly regulate conduction in Kir potassium channels. 2010, Pubmed
Clayton, Structure of the transmembrane regions of a bacterial cyclic nucleotide-regulated channel. 2008, Pubmed
Cordero-Morales, Molecular driving forces determining potassium channel slow inactivation. 2007, Pubmed , Xenbase
Cruse, Functional KCa3.1 K+ channels are required for human lung mast cell migration. 2006, Pubmed
Damkjaer, Pharmacological activation of KCa3.1/KCa2.3 channels produces endothelial hyperpolarization and lowers blood pressure in conscious dogs. 2012, Pubmed
Du, Theoretical study on the polar hydrogen-π (Hp-π) interactions between protein side chains. 2013, Pubmed
Félétou, Endothelium-dependent hyperpolarizations: past beliefs and present facts. 2007, Pubmed
Ferrer, The S4-S5 linker directly couples voltage sensor movement to the activation gate in the human ether-a'-go-go-related gene (hERG) K+ channel. 2006, Pubmed , Xenbase
Gao, Calcium-activated K(+) channel (K(Ca)3.1) activity during Ca(2+) store depletion and store-operated Ca(2+) entry in human macrophages. 2010, Pubmed
Garneau, Hydrophobic interactions as key determinants to the KCa3.1 channel closed configuration. An analysis of KCa3.1 mutants constitutively active in zero Ca2+. 2009, Pubmed
Gupta, Conformational changes during the gating of a potassium channel revealed by structural mass spectrometry. 2010, Pubmed
Hayashi, An intermediate-conductance Ca2+-activated K+ channel is important for secretion in pancreatic duct cells. 2012, Pubmed
Hirschberg, Gating of recombinant small-conductance Ca-activated K+ channels by calcium. 1998, Pubmed , Xenbase
Horovitz, Double-mutant cycles: a powerful tool for analyzing protein structure and function. 1996, Pubmed
Hougaard, Evidence for a common pharmacological interaction site on K(Ca)2 channels providing both selective activation and selective inhibition of the human K(Ca)2.1 subtype. 2012, Pubmed
Hougaard, Selective activation of the SK1 subtype of human small-conductance Ca2+-activated K+ channels by 4-(2-methoxyphenylcarbamoyloxymethyl)-piperidine-1-carboxylic acid tert-butyl ester (GW542573X) is dependent on serine 293 in the S5 segment. 2009, Pubmed
Jenkins, Negative gating modulation by (R)-N-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphthylamine (NS8593) depends on residues in the inner pore vestibule: pharmacological evidence of deep-pore gating of K(Ca)2 channels. 2011, Pubmed
Jo, CHARMM-GUI: a web-based graphical user interface for CHARMM. 2008, Pubmed
Joiner, Calmodulin regulates assembly and trafficking of SK4/IK1 Ca2+-activated K+ channels. 2001, Pubmed
Karplus, SAM-T08, HMM-based protein structure prediction. 2009, Pubmed
Klein, Structural determinants of the closed KCa3.1 channel pore in relation to channel gating: results from a substituted cysteine accessibility analysis. 2007, Pubmed , Xenbase
Klein, Inhibition of the KCa3.1 channels by AMP-activated protein kinase in human airway epithelial cells. 2009, Pubmed
Labro, The S4-S5 linker of KCNQ1 channels forms a structural scaffold with the S6 segment controlling gate closure. 2011, Pubmed
Lees-Miller, Interactions of H562 in the S5 helix with T618 and S621 in the pore helix are important determinants of hERG1 potassium channel structure and function. 2009, Pubmed
Liu, Change of pore helix conformational state upon opening of cyclic nucleotide-gated channels. 2000, Pubmed , Xenbase
Long, Voltage sensor of Kv1.2: structural basis of electromechanical coupling. 2005, Pubmed
Long, Crystal structure of a mammalian voltage-dependent Shaker family K+ channel. 2005, Pubmed
Lu, Coupling between voltage sensors and activation gate in voltage-gated K+ channels. 2002, Pubmed , Xenbase
Maylie, Small conductance Ca2+-activated K+ channels and calmodulin. 2004, Pubmed
Morales, Contribution of the KCa3.1 channel-calmodulin interactions to the regulation of the KCa3.1 gating process. 2013, Pubmed
Murthy, 4-Chlorobenzo[F]isoquinoline (CBIQ), a novel activator of CFTR and DeltaF508 CFTR. 2005, Pubmed , Xenbase
Proks, Mutations within the P-loop of Kir6.2 modulate the intraburst kinetics of the ATP-sensitive potassium channel. 2001, Pubmed , Xenbase
Prole, Reversal of HCN channel voltage dependence via bridging of the S4-S5 linker and Post-S6. 2006, Pubmed
Qin, Estimating single-channel kinetic parameters from idealized patch-clamp data containing missed events. 1996, Pubmed , Xenbase
Qin, Maximum likelihood estimation of aggregated Markov processes. 1997, Pubmed
Rosenhouse-Dantsker, New roles for a key glycine and its neighboring residue in potassium channel gating. 2006, Pubmed , Xenbase
Roth, The K+ channel opener 1-EBIO potentiates residual function of mutant CFTR in rectal biopsies from cystic fibrosis patients. 2011, Pubmed
Roy, I-TASSER: a unified platform for automated protein structure and function prediction. 2010, Pubmed
Sali, Comparative protein modelling by satisfaction of spatial restraints. 1993, Pubmed
Samanta, Packing of aromatic rings against tryptophan residues in proteins. 1999, Pubmed
Schumacher, Structure of the gating domain of a Ca2+-activated K+ channel complexed with Ca2+/calmodulin. 2001, Pubmed
Schumacher, Crystal structures of apocalmodulin and an apocalmodulin/SK potassium channel gating domain complex. 2004, Pubmed
Seebohm, Mutation of colocalized residues of the pore helix and transmembrane segments S5 and S6 disrupt deactivation and modify inactivation of KCNQ1 K+ channels. 2005, Pubmed , Xenbase
Sheng, Openers of SKCa and IKCa channels enhance agonist-evoked endothelial nitric oxide synthesis and arteriolar vasodilation. 2009, Pubmed
Simoes, Cysteine mutagenesis and computer modeling of the S6 region of an intermediate conductance IKCa channel. 2002, Pubmed , Xenbase
Singh, Benzimidazolone activators of chloride secretion: potential therapeutics for cystic fibrosis and chronic obstructive pulmonary disease. 2001, Pubmed , Xenbase
Szkotak, 4-Chloro-benzo[F]isoquinoline (CBIQ) activates CFTR chloride channels and KCNN4 potassium channels in Calu-3 human airway epithelial cells. 2004, Pubmed
Wall-Lacelle, Double mutant cycle analysis identified a critical leucine residue in the IIS4S5 linker for the activation of the Ca(V)2.3 calcium channel. 2011, Pubmed
Wang, A genetically encoded fluorescent amino acid. 2006, Pubmed
Wimley, Solvation energies of amino acid side chains and backbone in a family of host-guest pentapeptides. 1996, Pubmed
Wissmann, A helical region in the C terminus of small-conductance Ca2+-activated K+ channels controls assembly with apo-calmodulin. 2002, Pubmed , Xenbase
Wulff, Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant. 2000, Pubmed
Wulff, K+ channel expression during B cell differentiation: implications for immunomodulation and autoimmunity. 2004, Pubmed
